Cargando…

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe

BACKGROUND: Little is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. METHODS AND RESULTS: In the Prevention of Thromboembolic Events–European Registry in Atrial Fibrillation (n=6196 patients with atrial fibrillation; mean±SD age, 71.8±10.4 years;...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnabel, Renate B., Pecen, Ladislav, Rzayeva, Nargiz, Lucerna, Markus, Purmah, Yanish, Ojeda, Francisco M., De Caterina, Raffaele, Kirchhof, Paulus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015366/
https://www.ncbi.nlm.nih.gov/pubmed/29776959
http://dx.doi.org/10.1161/JAHA.117.007559
_version_ 1783334396221194240
author Schnabel, Renate B.
Pecen, Ladislav
Rzayeva, Nargiz
Lucerna, Markus
Purmah, Yanish
Ojeda, Francisco M.
De Caterina, Raffaele
Kirchhof, Paulus
author_facet Schnabel, Renate B.
Pecen, Ladislav
Rzayeva, Nargiz
Lucerna, Markus
Purmah, Yanish
Ojeda, Francisco M.
De Caterina, Raffaele
Kirchhof, Paulus
author_sort Schnabel, Renate B.
collection PubMed
description BACKGROUND: Little is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. METHODS AND RESULTS: In the Prevention of Thromboembolic Events–European Registry in Atrial Fibrillation (n=6196 patients with atrial fibrillation; mean±SD age, 71.8±10.4 years; 39.7% women), we assessed European Heart Rhythm Association score symptoms and calculated correlations with the standardized health status questionnaire (EQ‐5D‐5L). Patients were followed up for atrial fibrillation therapies and outcomes (stroke/transient ischemic attack/arterial thromboembolism, coronary events, heart failure, and major bleeding) over 1 year. Most individuals (92%) experienced symptoms. Correlations with health status and quality of life were modest. In multivariable‐adjusted regression models, the dichotomized European Heart Rhythm Association score (intermediate/frequent versus never/occasional symptoms) was associated with cardioversions (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.01–1.45) and catheter ablation (OR, 1.97; 95% CI, 1.44–2.69), and inversely related with heart rate control (OR, 0.80; 95% CI, 0.70–0.92) and heart failure incidence (OR, 1.65; 95% CI, 1.16–2.34). Anxiety was inversely related with stroke/transient ischemic attack/arterial thromboembolism (OR, 0.55; 95% CI, 0.32–0.93), whereas chest pain related positively with coronary events (OR, 2.45; 95% CI, 1.42–4.22). Fatigue (OR, 1.84; 95% CI, 1.30–2.60), dyspnea (OR, 2.33; 95% CI, 1.63–3.33), and anxiety (OR, 1.72; 95% CI, 1.16–2.55) were associated with heart failure incidence. Palpitations were positively associated with cardioversion (OR, 1.32; 95% CI, 1.08–1.61) and ablation therapy (OR, 2.02; 95% CI, 1.48–2.76). CONCLUSIONS: A higher symptom burden, in particular palpitations, predicted interventions to restore sinus rhythm. The score itself had limited predictive value, but its individual components were related to different and specific clinical events, and may thus be helpful to target patient management.
format Online
Article
Text
id pubmed-6015366
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60153662018-07-05 Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe Schnabel, Renate B. Pecen, Ladislav Rzayeva, Nargiz Lucerna, Markus Purmah, Yanish Ojeda, Francisco M. De Caterina, Raffaele Kirchhof, Paulus J Am Heart Assoc Original Research BACKGROUND: Little is known about the association of atrial fibrillation symptom burden with quality of life and outcomes. METHODS AND RESULTS: In the Prevention of Thromboembolic Events–European Registry in Atrial Fibrillation (n=6196 patients with atrial fibrillation; mean±SD age, 71.8±10.4 years; 39.7% women), we assessed European Heart Rhythm Association score symptoms and calculated correlations with the standardized health status questionnaire (EQ‐5D‐5L). Patients were followed up for atrial fibrillation therapies and outcomes (stroke/transient ischemic attack/arterial thromboembolism, coronary events, heart failure, and major bleeding) over 1 year. Most individuals (92%) experienced symptoms. Correlations with health status and quality of life were modest. In multivariable‐adjusted regression models, the dichotomized European Heart Rhythm Association score (intermediate/frequent versus never/occasional symptoms) was associated with cardioversions (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.01–1.45) and catheter ablation (OR, 1.97; 95% CI, 1.44–2.69), and inversely related with heart rate control (OR, 0.80; 95% CI, 0.70–0.92) and heart failure incidence (OR, 1.65; 95% CI, 1.16–2.34). Anxiety was inversely related with stroke/transient ischemic attack/arterial thromboembolism (OR, 0.55; 95% CI, 0.32–0.93), whereas chest pain related positively with coronary events (OR, 2.45; 95% CI, 1.42–4.22). Fatigue (OR, 1.84; 95% CI, 1.30–2.60), dyspnea (OR, 2.33; 95% CI, 1.63–3.33), and anxiety (OR, 1.72; 95% CI, 1.16–2.55) were associated with heart failure incidence. Palpitations were positively associated with cardioversion (OR, 1.32; 95% CI, 1.08–1.61) and ablation therapy (OR, 2.02; 95% CI, 1.48–2.76). CONCLUSIONS: A higher symptom burden, in particular palpitations, predicted interventions to restore sinus rhythm. The score itself had limited predictive value, but its individual components were related to different and specific clinical events, and may thus be helpful to target patient management. John Wiley and Sons Inc. 2018-05-18 /pmc/articles/PMC6015366/ /pubmed/29776959 http://dx.doi.org/10.1161/JAHA.117.007559 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Schnabel, Renate B.
Pecen, Ladislav
Rzayeva, Nargiz
Lucerna, Markus
Purmah, Yanish
Ojeda, Francisco M.
De Caterina, Raffaele
Kirchhof, Paulus
Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title_full Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title_fullStr Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title_full_unstemmed Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title_short Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
title_sort symptom burden of atrial fibrillation and its relation to interventions and outcome in europe
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015366/
https://www.ncbi.nlm.nih.gov/pubmed/29776959
http://dx.doi.org/10.1161/JAHA.117.007559
work_keys_str_mv AT schnabelrenateb symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT pecenladislav symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT rzayevanargiz symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT lucernamarkus symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT purmahyanish symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT ojedafranciscom symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT decaterinaraffaele symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope
AT kirchhofpaulus symptomburdenofatrialfibrillationanditsrelationtointerventionsandoutcomeineurope